Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-06-11 Capital/Financing Update
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Commercial Paper of ? 100 crores (Rupees One ....
Capital/Financing Update Classification · 100% confidence The document is a short official letter addressed to the stock exchanges (BSE and NSE) informing about the redemption of Commercial Papers issued by the company. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosures about material events. The content is an update on a financing activity (redemption of debt instrument). The document length is short (1273 characters), and it is not a financial report but a regulatory disclosure about capital structure activity. Therefore, it fits best under Capital/Financing Update (CAP).
2021-06-11 English
Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 9, 2021, addressed to the stock exchanges (BSE and NSE) regarding the schedule of an upcoming investor meeting on June 10 and 11, 2021. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain any financial data, results, or detailed presentations but simply informs about the schedule of an investor meet. The length is only 1499 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an investor meeting schedule and does not fit into more specific categories like Investor Presentation or Call Transcript, which would contain substantive content.
2021-06-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated June 9, 2021, addressed to the BSE Limited and NSE, informing about the schedule of an upcoming investor meet on June 10 and 11, 2021. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of a schedule for an investor meeting, not the meeting materials or transcript itself. The document length is only 1461 characters, indicating it is a brief notice rather than a detailed report or transcript. Therefore, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about an investor event schedule, not an investor presentation or call transcript.
2021-06-09 English
Pursuant to regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the Related Party Transactions on a consolidated basis ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 23(9). It encloses consolidated related party transactions for the half year ended 31-Mar-2021. The content includes detailed tables of related party transactions and balances for the half year period, remuneration details for key management personnel and independent directors, and terms and conditions of these transactions. The document is dated June 7, 2021, and pertains to a half-year period ending March 31, 2021. The document length is 4094 characters, which is relatively short but contains substantive financial data related to related party transactions for a half-year period. This is not a full interim or quarterly report but a specific regulatory compliance disclosure of related party transactions as required under SEBI regulations. Such disclosures are typically part of regulatory filings but given the detailed financial data and the nature of the disclosure, it fits best under Regulatory Filings (RNS) as it is a compliance disclosure rather than a full financial report like an interim report (IR). It is not an announcement of a report publication but the actual disclosure document. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-06-07 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a compliance disclosure pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 23(9), which mandates related party transactions disclosure. It provides detailed related party transactions and balances for the half year ended 31-Mar-2021. The document is addressed to stock exchanges (BSE and NSE) and signed by the company secretary. The content is a regulatory compliance filing disclosing related party transactions rather than a full financial report or management discussion. The document length is 4094 characters, which is relatively short and focused on a specific regulatory disclosure. This fits best under Regulatory Filings (RNS), as it is a compliance disclosure and does not constitute a full financial report or other specific filing types like Annual Report or Interim Report.
2021-06-07 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or financial data. The length is very short (176 characters), and there is no indication of any report, announcement, or filing type. Given the absence of any meaningful content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2021-06-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.